\nPotrivit unui comunicat al Ministerului S\u0103n\u0103t\u0103\u0163ii, Guvernul a aprobat Hot\u0103r\u00e2rea care prevede introducerea \u00een lista de medicamente compensate \u015fi gratuite a unui num\u0103r de 28 de molecule inovative, din care 22 de molecule noi, nelistate p\u00e2n\u0103 \u00een prezent \u015fi alte 6 molecule (Isavuconazolum, Adalimumabum, Dapagliflozinum, Rituximabum, Upadacitinibum si Apremilastum) introduse pentru alte indica\u0163ii dec\u00e2t cele pentru care sunt listate \u00een HG 720\/2008.<\/p>\n
\nMedicamentele inovative sunt destinate pacien\u0163ilor cu afec\u0163iuni de tipul: Hepatite cronice de etiologie viral\u0103 B, C \u015fi D, Ciroz\u0103 hepatic\u0103, Boala Parkinson \u015fi alte afec\u0163iuni neurologice, Colagenoze majore (lupus eritematos sistemic, sclerodermie, poli\/dermatomiozit\u0103, vasculite sistemice), Poliartrita reumatoid\u0103, artropatia psoriazic\u0103, psoriazis cronic sever \u015fi artrita juvenil\u0103, Boli endocrine \u015fi metabolice, Boala cronic\u0103 de rinichi – faza predializ\u0103, Boli degenerative ale ochiului (glaucom \u015fi boli maculare), Boala cronic\u0103 inflamatorie intestinal\u0103 \u015fi sindrom de intestin scurt, Poliartrita reumatoid\u0103, Artropatia psoriazic\u0103, Spondiloartrita axial\u0103, Psoriazis cronic sever.<\/p>\n
\n\u201eAccesul pacien\u0163ilor la medicamente inovative care salveaz\u0103 vie\u0163i este o preocupare constant\u0103 a Ministerului S\u0103n\u0103t\u0103\u0163ii \u00een ultimii doi ani. Num\u0103rul mare de molecule nou introduse \u00een lista de medicamente compensate \u015fi gratuite \u00een perioada 2022-2023 este cea mai bun\u0103 dovad\u0103 a responsabilit\u0103\u0163ii fa\u0163\u0103 de pacien\u0163i. Buna colaborare cu CNAS \u015fi organiza\u0163iile de pacien\u0163i fac posibile aceste progrese pentru care este nevoie de sprijinul Ministerului Finan\u0163elor. Pacien\u0163ii cu boli oncologice, neurologice \u015fi hepatite cronice au acces la noi molecule, iar acest lucru trebuie realizat f\u0103r\u0103 a afecta \u00een vreun fel accesul la medicamente generice care reprezint\u0103 resursa terapeutic\u0103 pentru 80% din pacien\u0163ii rom\u00e2ni. Oamenii au nevoie de aten\u0163ie \u015fi de empatie, deopotriv\u0103 din partea medicilor \u015fi a autorit\u0103\u0163ilor. \u00cempreun\u0103 lucr\u0103m pentru asta!\u201d, a declarat ministrul S\u0103n\u0103t\u0103\u0163ii, Alexandru Rafila.<\/p>\n
\nPotrivit comunicatului, programul na\u0163ional de oncologie se completeaz\u0103 cu \u015fase noi molecule de ultim\u0103 genera\u0163ie: Lipegfilgrastimum DCI, Tucatinibum DCI, Sacituzumab Govitecan DCI, Asciminibum DCI, Imunoglobulin\u0103 anti-limfocite DCI \u015fi Mosunetuzumabum DCI.<\/p>\n
\nActualizarea listei de medicamente compensate \u015fi gratuite intr\u0103 \u00een vigoare de la 1 mai 2024.<\/p>\n","protected":false},"excerpt":{"rendered":"
Ministerul S\u0103n\u0103t\u0103\u0163ii a anun\u0163at mar\u0163i c\u0103 extinde lista de medicamente compensate \u015fi gratuite pentru a cre\u015fte accesul pacien\u0163ilor cronici, cu afec\u0163iuni grave, la medicamente de ultim\u0103 genera\u0163ie.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[16656,54248,323],"class_list":["post-226115","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-compensate","tag-gratuite","tag-medicamente"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/226115","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=226115"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/226115\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=226115"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=226115"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=226115"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}